| Authors: |
Méant A; Lady Davis Institute, Jewish General Hospital, Montréal, Canada; Division of Experimental Medicine, Department of Medicine, McGill University, Montréal, Canada., Moussa O; Lady Davis Institute, Jewish General Hospital, Montréal, Canada; Division of Experimental Medicine, Department of Medicine, McGill University, Montréal, Canada., Lebeau B; Lady Davis Institute, Jewish General Hospital, Montréal, Canada; Division of Experimental Medicine, Department of Medicine, McGill University, Montréal, Canada; School of Biological Sciences, Nanyang Technological University, Singapore, Singapore., Gonçalves C; Lady Davis Institute, Jewish General Hospital, Montréal, Canada., Richard VR; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Canada., Cai F; Lady Davis Institute, Jewish General Hospital, Montréal, Canada; Division of Experimental Medicine, Department of Medicine, McGill University, Montréal, Canada., Prabhu SA; Lady Davis Institute, Jewish General Hospital, Montréal, Canada; Division of Experimental Medicine, Department of Medicine, McGill University, Montréal, Canada., Langke M; Lady Davis Institute, Jewish General Hospital, Montréal, Canada; Division of Experimental Medicine, Department of Medicine, McGill University, Montréal, Canada., Guettler EM; Lady Davis Institute, Jewish General Hospital, Montréal, Canada., Su J; Lady Davis Institute, Jewish General Hospital, Montréal, Canada., Gagnon N; Lady Davis Institute, Jewish General Hospital, Montréal, Canada., Zahedi RP; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Canada; Manitoba Centre for Proteomics and Systems Biology, University of Manitoba, Winnipeg, Canada., Borchers CH; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Canada; Department of Oncology, McGill University, Montréal, Canada., Miller WH Jr; Lady Davis Institute, Jewish General Hospital, Montréal, Canada; Division of Experimental Medicine, Department of Medicine, McGill University, Montréal, Canada; Department of Oncology, McGill University, Montréal, Canada., Del Rincón SV; Lady Davis Institute, Jewish General Hospital, Montréal, Canada; Division of Experimental Medicine, Department of Medicine, McGill University, Montréal, Canada; Department of Oncology, McGill University, Montréal, Canada. Electronic address: soniavictoria.delrincon@mcgill.ca., Witcher M; Lady Davis Institute, Jewish General Hospital, Montréal, Canada; Division of Experimental Medicine, Department of Medicine, McGill University, Montréal, Canada; Department of Oncology, McGill University, Montréal, Canada. Electronic address: michael.witcher@mcgill.ca. |
